These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 24950364)
21. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
22. Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier. Krupa A; Szlęk J; Jany BR; Jachowicz R AAPS PharmSciTech; 2015 Jun; 16(3):623-35. PubMed ID: 25501870 [TBL] [Abstract][Full Text] [Related]
23. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574 [TBL] [Abstract][Full Text] [Related]
24. Bioavailability of Celecoxib Formulated with Mesoporous Magnesium Carbonate-An In Vivo Evaluation. Zardán Gómez de la Torre T; Lindmark T; Cheung O; Bergström C; Strømme M Molecules; 2022 Sep; 27(19):. PubMed ID: 36234733 [TBL] [Abstract][Full Text] [Related]
25. Enhanced release of poorly water-soluble drugs from synergy between mesoporous magnesium carbonate and polymers. Yang J; Alvebratt C; Zhang P; Zardán Gómez de la Torre T; Strømme M; Bergström CAS; Welch K Int J Pharm; 2017 Jun; 525(1):183-190. PubMed ID: 28396244 [TBL] [Abstract][Full Text] [Related]
26. Biomimetic Synthesis and Evaluation of Interconnected Bimodal Mesostructured MSF@Poly(Ethyleneimine)s for Improved Drug Loading and Oral Adsorption of the Poorly Water-Soluble Drug, Ibuprofen. Xin W; Wang Y; Guo X; Gou K; Li J; Li S; Zhao L; Li H Int J Nanomedicine; 2020; 15():7451-7468. PubMed ID: 33116481 [TBL] [Abstract][Full Text] [Related]
27. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation. Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567 [TBL] [Abstract][Full Text] [Related]
28. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery. Wang C; He C; Tong Z; Liu X; Ren B; Zeng F Int J Pharm; 2006 Feb; 308(1-2):160-7. PubMed ID: 16359836 [TBL] [Abstract][Full Text] [Related]
29. Drug loading into porous calcium carbonate microparticles by solvent evaporation. Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of mesoporous carbon aerogels as carriers of the non-steroidal anti-inflammatory drug ibuprofen. Eleftheriadis GK; Filippousi M; Tsachouridou V; Darda MA; Sygellou L; Kontopoulou I; Bouropoulos N; Steriotis T; Charalambopoulou G; Vizirianakis IS; Van Tendeloo G; Fatouros DG Int J Pharm; 2016 Dec; 515(1-2):262-270. PubMed ID: 27717918 [TBL] [Abstract][Full Text] [Related]
31. Emerging trends in the stabilization of amorphous drugs. Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230 [TBL] [Abstract][Full Text] [Related]
32. Impact of in situ granulation and temperature quenching on crystal habit and micromeritic properties of ibuprofen-cationic dextran conjugate crystanules. Abioye AO; Kola-Mustapha A; Ruparelia K Int J Pharm; 2014 Feb; 462(1-2):83-102. PubMed ID: 24378327 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Heikkilä T; Salonen J; Tuura J; Kumar N; Salmi T; Murzin DY; Hamdy MS; Mul G; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP Drug Deliv; 2007 Aug; 14(6):337-47. PubMed ID: 17701523 [TBL] [Abstract][Full Text] [Related]
34. Refining stability and dissolution rate of amorphous drug formulations. Grohganz H; Priemel PA; Löbmann K; Nielsen LH; Laitinen R; Mullertz A; Van den Mooter G; Rades T Expert Opin Drug Deliv; 2014 Jun; 11(6):977-89. PubMed ID: 24754747 [TBL] [Abstract][Full Text] [Related]
35. Formulation and delivery strategies of ibuprofen: challenges and opportunities. Irvine J; Afrose A; Islam N Drug Dev Ind Pharm; 2018 Feb; 44(2):173-183. PubMed ID: 29022772 [TBL] [Abstract][Full Text] [Related]
36. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Prabhu S; Ortega M; Ma C Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087 [TBL] [Abstract][Full Text] [Related]
37. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres. Adeyeye CM; Price JC J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285 [TBL] [Abstract][Full Text] [Related]
38. Increasing the Transport of Celecoxib over a Simulated Intestine Cell Membrane Model Using Mesoporous Magnesium Carbonate. Gómez de la Torre J; Bergström C; Zardán Gómez de la Torre T Molecules; 2021 Oct; 26(21):. PubMed ID: 34770762 [TBL] [Abstract][Full Text] [Related]
39. In-situ forming implants for the treatment of periodontal diseases: Simultaneous controlled release of an antiseptic and an anti-inflammatory drug. Lizambard M; Menu T; Fossart M; Bassand C; Agossa K; Huck O; Neut C; Siepmann F Int J Pharm; 2019 Dec; 572():118833. PubMed ID: 31715363 [TBL] [Abstract][Full Text] [Related]
40. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution. Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]